International Trade in the Health Sector: Forgotten Frontier? by Khorana, Sangeeta
Background
Global exports of health care goods and services
have grown in recent years, with trade in services
increasing substantially between 1996 and 2013.
The growing trade in health care goods and
services is primarily attributed to the changing
patterns of world demand and supply factors.
Demand drivers include the changing demographic
pattern of the world’s population, that is, an
increase in ageing populations in the developed
world, and this complemented by a growing skilled
work force in developing countries has generated
trade in health care products and services. Other
factors include continued tariff reductions, the
liberalisation of cross-border movement of
professionals and investment in health-related
services, as well as the emergence of new
technologies (i.e. big data explosion). Mobile health
technologies have spurred further activity in health
trade, in particular health services. While on the
one hand increasing demand has revolutionised
the provision of health services and products, it is,
on the other hand, putting pressure on national
governments and policy-makers to supply quality
health care facilities to populations at a time when
governments are looking to reduce public
spending on social services. This is especially the
case in the European Union, where an ageing
population, strict patent laws and the growing
production of generic drugs by emerging
economies such as Brazil, China and India are
pushing the boundaries of health policy-making.
Trade agreements may also have major
implications for global health and national health
systems. For example, trade agreements could
reduce governments’ policy space to respond to
public health issues, including universal health
coverage, while trade in tobacco products and
other unhealthy foods may have harmful effects
and even contribute to an ‘epidemic’ of obesity and
related non-communicable diseases. On a positive
note, global trade can contribute to transforming
the health sector, including through telemedicine,
distant training of health workers, and the diffusion
of other health technologies. While recognising
these wider debates and the need for greater
policy coherence between the trade and health
sectors,1 this issue of Commonwealth Trade Hot
Topics specifically provides an overview of
international trade in health care goods and
services including the work force and highlights
some of the trade opportunities and challenges,
especially for developing countries.
International Trade in the Health
Sector: Forgotten Frontier?
Sangeeta Khorana*
Is
su
e
12
6
|2
01
6
Trade
Hot Topics
ISSUE 126
* Sangeeta Khorana is Professor of Economics, Bournemouth University, United Kingdom. The views expressed in this article are those
of the author and do not necessarily represent those of the Commonwealth Secretariat.
1 Commonwealth Secretariat, ‘Trade Agreements and Health’, draft briefing paper prepared by the Health and Education Unit, February
2016.
  
Trade in health goods and services
Trade in health can be broadly classified into three
groups: (a) trade in goods, which includes health care
equipment, drugs, and medical waste; (b) services
that include both health and medical services;2 and
(c) ancillary services, including medical transcription,
medical research, medical insurance, and distance
medical education and training.
Trade in health care products
Trade flow estimates for health care goods, in both
developed and developing countries, exhibit an
upward trend over the period 1996–2014 (Figure
1). In value terms, total trade in health care
products has grown from less than US$50 billion in
1995 to over US$875 billion in 2014. Within this
sector, pharmaceuticals and non-durables (e.g.
topical dressing for wounds) registered a manifold
increase suggesting that the significance of trade
in health care products is on the rise, mainly due to
the demand drivers as discussed earlier.
Trade in health products is primarily concentrated
in four groups, namely: inputs specific to the
pharmaceuticals industry (HS code 29); bulk
medicines (HS30); hospital and laboratory inputs
(HS38); and medical technology instruments
(HS90). These four groups account for nearly 98
per cent of all trade in health care products. Other
product groups, that is, HS 35, 38, 40, 70, 84, 87 90
and 94,3 have a small 2 per cent share in total health
products trade, suggesting concentration in a few
HS groups. 
There is also concentration of trading partners.
Developed countries such as the USA, Germany,
Belgium, France and the UK are the main trading
countries in health goods. Developing countries
have low participation, with the exception of China,
Brazil and India, which are major suppliers of
diagnostic equipment and pharmaceuticals. It
should also be noted that developing countries’
total export value is low compared to developed
countries. An example is India, which despite being
the largest global provider of generic drugs, has a
share value of only 1.4 per cent in the global
pharmaceutical industry.4 Across Organisation for
Economic Co-operation and Development (OECD)
countries, the total pharmaceutical spending (on
generic and patented drugs) is US$800 billion and
this accounts for nearly 20 per cent of total health
spending on average. While some OECD countries,
including Switzerland, Italy, Greece and Japan,
have introduced policies to boost the generics
market, the share of these drugs remains small.
These measures to boost the generics market
include reducing ex-factory prices of on-patent
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2 Examples of such health services include: telemedicine (mode 1); medical tourism (mode 2); foreign participation or ownership of hospital
(mode 3); and movement of doctors and health personnel for the purpose of commercial medical practice (mode 4).
3 HS35 and 38 include products classified as Medical equipment and other inputs; HS40 includes items such as non-durables surgical gloves
of vulcanised rubber; HS70 includes items such as Laboratory, hygienic or pharmaceutical glassware; HS84 includes Medical, surgical or
laboratory sterilisers; HS87 includes Carriages for disabled persons; HS90 includes medical equipment such as Electro-cardiographs;
HS94 relates to Operating related furniture.
4 India Brand Equity Foundation (2015), India Pharmaceuticals Industry: Sectoral Report, August. Available at http://www.ibef.org/
industry/pharmaceutical-india.aspx#sthash.fLrx9cxB.dpuf (accessed 6 February 2016). 
Figure 1: Global Exports of Health Care Goods from 1996 to 2014 (US$ billion)
Source: UNCOMTRADE, 2015
and/or generic drugs (e.g. Greece, Ireland, Portugal
and Spain) and reducing distribution margins for
some categories of medicines.
Trade in health services 
According to one estimate, global trade in health
services has doubled since 2003.5 So, for example,
‘over 1 million people travel to Asia each year to
receive health care, contributing some US$2 billion
to the region’s economy. Over 50 per cent of
doctors trained in Ghana emigrate. Cuba is a
regional hub for tele-radiology services. Private
companies from India, Singapore and elsewhere
invested more than US$1 billion [in 2007]
establishing hospitals or other ventures abroad.’6
Trade in health services constitutes trade in the
following categories: (a) Mode 1 ‘cross-border
supply’, where the service, but neither producer
nor consumer, crosses a border; (b) Mode 2
‘consumption abroad’, where the consumer
crosses a border to obtain a service; (c) Mode 3
‘commercial presence’, where companies engage
in foreign direct investment (FDI) in the service
sector of another country; and (d) Mode 4, which
includes ‘temporary movement of service
providers’, where skilled workers move to other
countries to work for a limited period. 
There is no comprehensive database that
captures the different modes of trade in services,
especially in health services. Two available data
sources for Modes 1, 2 and 4 are the International
Monetary Fund’s ‘Balance of Payments Statistics’
(BOPS) database and the United Nations Services
Trade data. Analysis of the data suggests there
are limitations to the IMF’s BOPS. First, health
services are included as a sub-category of ‘travel’,
which is ‘health-related travel expenditure’, and
data is available on export of health services only.
Second, data is aggregate for 2005 to 2012, with
many missing values. The UN Services Trade
presents a similar case, where data on Mode 2 is
available, but bilateral data is available for only 57
exporting and 76 importing countries for 2000 to
2012. Given limited statistics on Mode 2, OECD
data is used below to analyse health-related
travel exports.
Health-related travel exports: OECD statistics on
Mode 2 services – that is, medical tourism –
provides data on ‘health-related travel
expenditure’ for the period 2000–2011. Figure 2
draws on the OECD data on health tourism and
shows that the exports of health-related travel (i.e.
medical tourism) have registered an increase in
international health services trade in the last
decade, in particular since 2004. Developing
countries are the main suppliers of medical
services under health tourism, and among these
Thailand, Malaysia and India rank as top players. 7
What makes these countries the main players is
that these economies enjoy cost advantage over
other countries and are able to deliver high quality
health care at a lower cost due to the availability of
highly skilled labour (including physicians and
nurses) and capital at lower cost. In some
countries, there are also policy initiatives by
governments (state, local, or in some cases both)
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5 Smith, R D, Blouin, C, Drager, N and Fidler, D P (2007), ‘Trade in health services and the GATS’, in Mattoo, A, Stern R M and Zanini, G (eds),
A handbook of international trade in services, Oxford: Oxford University Press.
6 Ibid.
7 Bookman, M Z and Bookman, K R (2007), Medical Tourism in Developing Countries, Palgrave Macmillan, New York, pp. 1–19; Lunt, N, Smith,
R et al. (2011), Medical tourism: treatments, markets and health system implications: a scoping review, OECD, Paris.
Figure 2: OECD Exports of Health-related Travel (US$ billion)
Source: OECD (2015)
to promote health tourism through official tourism
agencies. In addition, governments often also allow
financial and non-financial incentives to foster
health services trade.8
Health services in modes 1 and 4: The IMF's BOPS
and UN Services Trade data show that developing
countries exhibit an increase in export of
professionals under this mode of services trade,
especially from 2003 on, and exports have grown
remarkably from 2005 to 2008. Since 2008, the
movement has shown a downward trend, and has
fallen sharply. 
FDI in health services: Since there is no data on FDI
flows specifically into the medical sector, data on
mode 3 is usually drawn from secondary sources.9
Statistics indicate that the health and social
services sector attracts a small share of world FDI
flows. FDI into the health sector has increased
between 2000 and 2010. In fact, some spikes are
observed in FDI, such as investment into health
and social services, although flows have remained
relatively stable over 2001–2010. Developing
countries, however, exhibit variations – some have
larger number of foreign companies located
regardless of the country’s size.
The increase in FDI in health care is mainly
attributed to phenomenal growth in mobile health
technologies and the use of wearable and
implantable sensors. These ‘new’ technologies are
revolutionising health care and leading to
investments by governments in health
technologies.10 While ‘new’ technologies are
transforming health care (delivered primarily in
hospitals and clinics) into health (managed
wherever the patient is), they are also impacting on
the level of international trade and total spending
by governments across countries.
International trade, development and health 
Health has long been recognised as an integral part
of the global development agenda. Sustainable
Development Goal 3 (SDG 3) of the 2030 Agenda
for Sustainable Development specifically aspires
to ensure good health and well-being for all. This
includes a bold commitment to end AIDS,
tuberculosis, malaria and other communicable
diseases by 2030. In addition, it aspires to achieve
universal health coverage, and provide access to
safe and effective medicines and vaccines for all.
Supporting research and development for
vaccines is an essential part of this process, as well
as expanding access to affordable medicines.
These health-related goals should be situated
within the global trade governance framework.
International trade in health products and
services is governed by various World Trade
Organization (WTO) agreements, including those
on Technical Barriers to Trade (TBT), Sanitary and
Phytosanitary Measures (SPS), Trade-Related
Intellectual Property Rights (TRIPS) and the
General Agreement on Trade in Services (GATS).
In particular, TRIPS (Article 8) provides for rules
on compulsory licensing, parallel importation and
the application of patent law and is relevant for
developing countries. On 30 August 2003, the
General Council of the WTO adopted the Decision
on Implementation of Paragraph 6 of the Doha
Declaration on the TRIPS Agreement and Public
Health (the August Decision). The Decision
makes access to patent protected medicines
easier for countries with insufficient domestic
manufacturing capacities in the pharmaceutical
sector and provides for the possibility of granting
such compulsory licences for export purposes by
waiving the application of the relevant provisions
of the TRIPS Agreement. 
The interpretation of TRIPS commitments has led
to instances of case law relating to extraterritorial
application of national laws with implications for
developing countries. An example is European
Union–Seizure of Generic Drugs in Transit
(WT/DS408, May 2011), which, following the
seizure of generic drugs exported by India to Brazil,
has been termed an ‘excessive and inappropriate
interpretation’ of intellectual property law.
Another case is Canada–Pharmaceuticals
(WTO/DS114), which allows countries to permit
manufacturers of generic drugs to use the
patented invention without the patent owner’s
permission and before the patent protection
expires, for the purpose of obtaining marketing
approval from public health authorities. 
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8 Reisman, D (2010), ‘Health tourism and public policy’, in Health Tourism: Social Welfare through International Trade, Edward Elgar Publishing
Limited, Cheltenham, pp. 118–147.
9 Culyer, A J (ed.) (2014), Encyclopaedia of Health Economics, Elsevier. 
10 EYGM (2015), ‘Megatrends 2015: Making sense of a world in motion’. At http://www.ey.com/Publication/vwLUAssets/ey-megatrends-
report-2015/$FILE/ey-megatrends-report-2015.pdf (accessed 6 February 2016). 
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Another WTO agreement with equally far reaching
implications for developing countries is the GATS,
which includes commitments by member countries
on cross-border delivery of health services. The
agreement has been debated from the perspective
of developing countries. There is evidence in the
literature to suggest that GATS may have the
potential to limit regulatory jurisdiction and choice
of developing countries to the detriment of social
service efficiency, equity, and quality in these
countries, which is a matter of concern from small
developing countries’ perspective.
In addition to regulations at the multilateral level,
there are bilateral, regional and preferential
agreements that include specific commitments
from member countries to liberalise health care
services. While there are no exhaustive analyses
focusing on health services liberalisation,
preliminary analysis of professional services
liberalised within the bilateral framework suggests
that countries have committed to GATS-like
undertakings, though the level of liberalisation
varies between agreements. For instance, Malaysia,
Mexico and Vietnam have undertaken
commitments under the recently concluded Trans-
Pacific Partnership (TPP) Agreement that will give
TPP member countries’ providers of private health
and allied health services greater access and
operating conditions in these countries. 
However, not all bilateral agreements are similar
and commitments undertaken by the Andean
Community (under mode 4) list reservations
specific to health-related professional services for
the migration of health workers in Bolivia, Colombia
and Ecuador. ASEAN similarly allows only the
movement of experienced medical professionals in
the South-East Asia region. For example, ASEAN
commitments list that medical and dental
practitioners and nurses should have a minimum of
five and three years of work experience,
respectively in the country of origin. Health
insurance is also not portable within ASEAN. Thus,
in effect, despite the best endeavours and
commitments to reform trade, there is incomplete
liberalisation in the health sector.
Intellectual property rights (IPRs) are another issue
that is rapidly gaining prominence at bilateral level,
although the level of IPR commitments between
the partner countries varies. Analysis suggests
that TRIPS-plus standards are a norm in bilateral
agreements, and increasingly a common feature of
bilateral and regional trade agreements. These IPR
commitments often exceed the WTO TRIPS
Agreement in that they provide for wider
applicability and extended patent protection for
pharmaceuticals, and impose penalties for non-
compliance and violation of commitments by
partner countries.
The TPP is no exception. While it reaffirms
participating countries’ commitment to the WTO’s
2001 Declaration on the TRIPS Agreement and
Public Health, it does include a specific chapter with
commitments that have implications for the health
sector. This agreement includes commitments on
pharmaceutical-related provisions, which relate to
the development of innovative medicines and the
availability of generic medicines. The chapter also
includes commitments on the protection of
undisclosed tests and other data submitted to
obtain marketing approval of a new pharmaceutical
or agricultural-chemicals product. 
Conclusion and way forward
The SDGs explicitly recognise health as a
precondition for and outcome of policies to
promote sustainable development, which
highlights the importance of health trade from the
perspective of developing and low-income
countries. While globalisation has fuelled a steady
growth in international trade of health care goods
and services, with health services growing fastest
in the world economy, the challenges for
development especially for small states remain.
The development challenge is magnified by lack of
data on trade in health goods and services. As a
result, it is not possible to measure the total value
of international trade in health services. In the
absence of health trade data, the mapping of
health services supply, in line with the GATS
modes, is not possible. The paucity of data thus
makes the quantification of health trade a
formidable challenge. 
Of late, services trade has grown and this is mainly
attributed to bilateral, regional and multilateral
liberalisation of the health sector. While this has
ushered in new opportunities for developing
countries, in particular for emerging economies as
a destination for health tourism, the movement of
health care professionals from the developing to
developed countries is an area of growing concern.
In particular, emigration of trained health care
professionals from the emerging and larger
developing countries is resulting in ‘brain drain’ and
eroding the already weak technical capacity base of
developing countries. Other relevant issues from
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the perspective of developing and low-income
countries are IPR protection and access to
affordable medicines. On the one hand, the
flexibilities under TRIPS have promoted access to
medicines in developing countries and emerging
economies and some countries have become the
‘pharmaceutical factory’ for generic drugs and
medicines for HIV-AIDS and tuberculosis. But, on
the other hand, the gains from TRIPS have varied
across developing countries depending on the
level of their development, with some gaining more
than others. 
Given that globalisation influences health trade and
health policy-making, it is imperative to manage
liberalisation from a developmental perspective so
that potential benefits for developing countries as a
group are maximised. In this context, designing
development focused international rules and
institutions that promote and support national
policies and activities especially in small and low-
income developing countries are critical. Special
attention needs to be paid to the requirements of
the emerging and larger developing countries if
these countries are to benefit from growing trade.
For instance, the existing barriers to health trade
need addressing so that this group of countries can
participate in health services trade effectively.
Thus, for all developing countries to benefit from
increasing trade in health a concerted and
collaborative partnership between governments
and international institutions is needed – to
address the tensions between the goals of
protecting health, promoting trade in goods,
services and investment capital, and effectively
adjusting to and managing health policy concerns.
While these are challenges in themselves, there are
indeed opportunities for developing countries to
enhance their participation in global health trade
and benefit from their competitive advantage in
health services trade. 
International Trade Policy Section at the
Commonwealth Secretariat
This Trade Hot Topic is brought out by the International Trade Policy (ITP) Section of the Trade Division of
the Commonwealth Secretariat, which is the main intergovernmental agency of the Commonwealth – an
association of 53 independent states, comprising large and small, developed and developing, landlocked
and island economies – facilitating consultation and co-operation among member governments and
countries in the common interest of their peoples and in the promotion of international consensus-building.
ITP is entrusted with the responsibilities of undertaking policy-oriented research and advocacy on trade and
development issues and providing informed inputs into the related discourses involving Commonwealth
members. The ITP approach is to scan the trade and development landscape for areas where orthodox
approaches are ineffective or where there are public policy failures or gaps, and to seek heterodox
approaches to address those. Its work plan is flexible to enable quick response to emerging issues in the
international trading environment that impact particularly on highly vulnerable Commonwealth
constituencies – least developed countries (LDCs), small states and sub-Saharan Africa.
Scope of ITP Work
ITP undertakes activities principally in three broad
areas:
• It supports Commonwealth developing members
in their negotiation of multilateral and regional
trade agreements that promote development
friendly outcomes, notably their economic growth
through expanded trade.
• It conducts policy research, consultations and
advocacy to increase understanding of the
changing international trading environment and
of policy options for successful adaptation.
• It contributes to the processes involving 
the multilateral and bilateral trade regimes 
that advance more beneficial participation of
Commonwealth developing country members,
particularly, small states and LDCs and sub-
Saharan Africa.
ITP Recent Activities
ITPs most recent activities focus on assisting
member states in their negotiations under the
WTO’s Doha Round and various regional trading
arrangements, undertaking analytical research on
a range of trade policy, emerging trade-related
development issues, and supporting workshops/
dialogues for facilitating exchange of ideas,
disseminating informed inputs, and consensus-
building on issues of interest to Commonwealth
members.
Selected Recent Meetings/Workshops
Supported by ITP
16 - 18 December 2015: The 2030 Sustainable
Development Agenda and the Multilateral Trading
System, held in Nairobi, Kenya.
12 -13 November 2015: Emerging Global and
Regional Trade Issues for the Commonwealth
Pacific Region, held in Tonga. 
15 - 16 October 2015: Meeting for Commonwealth
Caribbean Countries in Preparation for the 10th 
WTO Ministerial Conference, held in Bridgetown,
Barbados.
29 September - 1 October 2015: Expert Group
Meeting on Trade in Sustainable Fisheries, held in
Geneva, Switzerland.
23 - 24 June 2015: Commonwealth Trade
Symposium: 'Shaping a Global Trade Agenda for
Development', held in Johannesburg, South Africa.
18 - 19 June 2015:  Workshop for Commonwealth
African Countries in Preparation for the 10th WTO
Ministerial Conference, held in Kigali, Rwanda.
18 May 2015: Workshop on Post-Bali Issues and
Preparation for the 10th WTO Ministerial
Conference: A South Asia Perspective, held in
Colombo, Sri Lanka.
25 - 26 March 2015: Consultative Meeting of
Commonwealth Expert Group on Trade, held in
Malta.
3 March 2015: Meeting of Market Access and Other
Issues relevant to Small States in Geneva: Options in
the Post-Bali Context, held in Geneva, Switzerland.
15-16 December 2014:  International Conference
on ‘Mega Trading Blocs: Implications for Developing 
Countries’ held in New Delhi, India
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